| Bioactivity | Rosonabant is a selective antagonist for cannabinoid receptor (CB1 receptor), which reduces body weight and improves improves the risk of obesity-related cardiovascular metabolic diseases. Rosonabant exhibits adverse side effect, such as nausea and mental disorder[1]. |
| CAS | 861151-12-4 |
| Formula | C21H21Cl3N4O |
| Molar Mass | 451.78 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Janero DR, et al., Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin Emerg Drugs. 2009 Mar;14(1):43-65. |
Rosonabant
CAS: 861151-12-4 F: C21H21Cl3N4O W: 451.78
Rosonabant is a selective antagonist for cannabinoid receptor (CB1 receptor), which reduces body weight and improves imp
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.